11 Results for "

DUSP6

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "DUSP6" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-115502
CAS No.: 1245792-51-1
Purity:  99.73%
Synonyms: (E)-BCI
Target:  

Phosphatase

Research Areas:  

Inflammation/Immunology

BCI ((E)-BCI) is a DUSP6 (dual specificity phosphatase 6) inhibitor. BCI shows anti-inflammatory activity and decreases reactive oxygen species (ROS) production. BCI can be used in inflammatory disease research .
loading...
    loading...
17
17 Publications Verification
Cat. No.: HY-115502A
CAS No.: 95130-23-7
Purity:  99.93%
Synonyms: (E)-BCI hydrochloride
Target:  

Phosphatase

Research Areas:  

Inflammation/Immunology

BCI ((E)-BCI) hydrochloride is a DUSP6 (dual specificity phosphatase 6) inhibitor. BCI hydrochloride shows anti-inflammatory activity and decreases reactive oxygen species (ROS) production. BCI hydrochloride can be used in inflammatory disease research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-126390
CAS No.: 15982-84-0
Synonyms: NSC 150117
Target:  

Phosphatase Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

(E/Z)-BCI (NSC 150117) is a dual-specificity phosphatase 6 (DUSP6) inhibitor with anti-inflammatory activities. (E/Z)-BCI attenuates LPS-induced inflammatory mediators and ROS production in macrophage cells via activating the Nrf2 signaling axis and inhibiting the NF-κB pathway .
loading...
    loading...
Cat. No.: HY-RS04067
Research Areas:  

Others

DUSP6 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17007
Research Areas:  

Others

Dusp6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Dusp6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23450
Research Areas:  

Others

Dusp6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Dusp6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-168012
CAS No.: 3054023-07-0
Target:  

Ras Phosphatase

Research Areas:  

Cancer

Pan-RAS-IN-6 (compound 24) is an inhibitor targeting DUSP6, which reduces MAPK activation in the brain of the NCI-H1373-Luc model (DUSP6), at the same time, it shows significant tumor growth inhibition and tumor regression effects in the NSCLC brain metastasis mouse model. Pan-RAS-IN-6 shows high selectivity and strong inhibitory effects, especially in KRAS mutation-related signaling pathways, demonstrating varying inhibitory activity against different KRAS mutants and interacting proteins. The IC50 values for KRAS G12C, G12D, and G12V are 1.3 nM, 4.7 nM, and 0.3 nM, respectively .
loading...
    loading...
Cat. No.: HY-P82535
Synonyms: HH19; MKP3; PYST1; DUSP6; DUSP6a; Dual specificity phosphatase 6

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P82535A
Synonyms: HH19; MKP3; PYST1; DUSP6; DUSP6a; Dual specificity phosphatase 6

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-184892
CAS No.: 2953305-55-8
Target:  

Ras Raf PERK p38 MAPK Apoptosis

Research Areas:  

Cancer

RMC-8839 is an orally active selective RAS (ON) G13C inhibitor with a Ki value of 28.3 nM. RMC-8839 disrupts the interaction between KRAS G13C and RAF1 (RBD). RMC-8839 inhibits RAS-MAPK pathway signaling by reducing DUSP6 mRNA levels and pERK levels. RMC-8839 induces cytotoxicity, apoptosis (apoptosis) and antiproliferative effects in KRAS G13C-mutated cells. RMC-8839 induces tumor stasis or regression in mice. RMC-8839 can be used in research related to non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-181889
Target:  

Ras

Research Areas:  

Cancer

KRAS G12C-IN-75 is an orally active, blood-brain barrier penetrant KRAS G12C inhibitor with an IC50 of 0.53 nM. KRAS G12C-IN-75 attenuates active transport mediated by P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). KRAS G12C-IN-75 inhibits tumor growth, regulates the expression of downstream MAPK target genes DUSP6 and SPRY4, and exhibits dose-dependent KRAS G12C alkylation in KRAS G12C-positive xenograft models. KRAS G12C-IN-75 can be used for research related to non-small cell lung cancer .
loading...
    loading...
  • 1